P27 JUMC

From LipidomicsWiki

(Difference between revisions)
Jump to: navigation, search
Line 6: Line 6:
|myAbout=
|myAbout=
|myContribution=The Dembinska-Kiec lab brings access to patients with diabetes, metabolic syndrome and HIV. They have unique access to adipose tissue from HIV patients treated with protease inhibitors which generates lipodystrophy. They also can provide genetic and lipidomic analysis of such tissue.
|myContribution=The Dembinska-Kiec lab brings access to patients with diabetes, metabolic syndrome and HIV. They have unique access to adipose tissue from HIV patients treated with protease inhibitors which generates lipodystrophy. They also can provide genetic and lipidomic analysis of such tissue.
-
|myTaskforces=
+
|myTaskforces=[[TASK_FORCE_II|TASK_FORCE_II]], [[TASK_FORCE_IV|TASK_FORCE_IV]], [[TASK_FORCE_IVI|TASK_FORCE_IVI]], and [[TASK_FORCE_IVIX|TASK_FORCE_IVIX]]
-
|myWorkpackages=
+
|myWorkpackages=[[WP4|WP4]] and [[WP8|WP8]]
}}<br> <br>  
}}<br> <br>  
[[Category:Project_organisation]]
[[Category:Project_organisation]]

Revision as of 06:59, 16 June 2011

InstitutionJagiellonian University Medical College - Prof. Aldona Dembinska-Kieć MD PhD
Principal investigator {{{myPrincipal_investigator}}}
Country Poland
Beneficiary NumberP09
About us
ContributionsThe Dembinska-Kiec lab brings access to patients with diabetes, metabolic syndrome and HIV. They have unique access to adipose tissue from HIV patients treated with protease inhibitors which generates lipodystrophy. They also can provide genetic and lipidomic analysis of such tissue.
Member of TaskforcesTASK_FORCE_II, TASK_FORCE_IV, TASK_FORCE_IVI, and TASK_FORCE_IVIX
Member of WorkpackagesWP4 and WP8

Back to List of Beneficiaries




Personal tools
Create a book